Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
BMC Health Serv Res ; 23(1): 146, 2023 Feb 11.
Article in English | MEDLINE | ID: covidwho-2262664

ABSTRACT

BACKGROUND: People in low- and middle-income countries are disproportionately affected by Noncommunicable diseases (NCDs). NCD's such as heart disease, cancer, chronic respiratory disease, and diabetes, are the leading cause of premature death worldwide and represent an emerging global health threat. The purpose of this qualitative study was to explore decision makers perceptions of developing population-level interventions (policies and programmes), targeting risk factors for hypertension and diabetes, in South Africa. METHODS: Using purposive sampling we recruited fifteen participants, who were well informed about the policies, programs or supportive environment for prevention and management of diabetes and hypertension in South Africa. We conducted 12 individual interviews and 1 group interview (consisting of 3 participants). Data was analysed thematically in NVivo. The results were shared and discussed in two consultative stakeholder workshops, with participants, as part of a member validation process in qualitative research. All communication with participants was done virtually using MS Teams or ZOOM. RESULTS: For development of population-level interventions, key enablers included, stakeholders' engagement and collaboration, contextualization of policies and programs, and evaluation and organic growth. Challenges for supportive policy and program formulation, and to enable supportive environments, included the lack of time and resources, lack of consultation with stakeholders, regulations and competing priorities, and ineffective monitoring and evaluation. The main drivers of population-level interventions for diabetes and hypertension were perceived as the current contextual realities, costs, organizational reasons, and communication between various stakeholders. CONCLUSION: To address the risk factors for hypertension and diabetes in South Africa, policies and programs must account for the needs of the public and the historical and socio-economic climate. Feasibility and sustainability of programs can only be ensured when the resources are provided, and environments enabled to promote behavior change on a population-level. A holistic public health approach, which is contextually relevant, and evidence informed, is considered best practice in the formulation of population-level interventions.


Subject(s)
Diabetes Mellitus , Hypertension , Humans , Decision Making , Diabetes Mellitus/epidemiology , Diabetes Mellitus/prevention & control , Health Policy , Hypertension/epidemiology , Hypertension/prevention & control , Qualitative Research , Risk Factors , South Africa/epidemiology
2.
J Prim Care Community Health ; 14: 21501319231158285, 2023.
Article in English | MEDLINE | ID: covidwho-2276716

ABSTRACT

BACKGROUND: The Stanford Youth Diabetes Coaching Program (SYDCP) is an evidence-based program led by health care professionals to teach healthy youth who then coach family members with diabetes or other chronic conditions. This purpose of this study is to evaluate a Community Health Worker (CHW)-led implementation of the SYDCP for low-income Latinx students from underserved agricultural communities. METHOD: CHWs were trained and virtually led 10 training sessions virtually during the COVID-19 for Latinx students who were recruited from high schools in agricultural regions of Washington state. Feasibility measures include recruitment, retention, class attendance, and successful coaching of a family member or friend. Acceptability was measured by responses on the post-training survey. Effectiveness was evaluated by pre-post changes in measures used in prior studies of the SYDCP such as level of activation and diabetes knowledge. RESULTS: Thirty-four students were recruited, 28 completed the training and 23 returned both pre- and post-surveys. Over 80% of students attended 7 or more classes. All met with a family or friend and 74% met with them weekly. Approximately 80% of the students rated the program's usefulness as "very good" or "excellent." Pre-post increases in diabetes knowledge, nutrition-related behaviors, resilience, and activation were significant and similar to those observed in prior published studies of the SYDCP. CONCLUSIONS: Findings support the feasibility, acceptability, and effectiveness of a CHW-led implementation of the SYDCP in underserved Latinx communities using a virtual remote model.


Subject(s)
Diabetes Mellitus , Mentoring , Adolescent , Humans , Community Health Workers/education , Diabetes Mellitus/prevention & control , Hispanic or Latino
3.
Epidemiol Health ; 45: e2023014, 2023.
Article in English | MEDLINE | ID: covidwho-2226003

ABSTRACT

OBJECTIVES: This study aimed to analyze the changes in chronic disease management indicators, including hypertension, diabetes mellitus, and hypercholesteremia, from 2010-2020 and before (2019) and during (2020) the coronavirus disease 2019 (COVID-19) pandemic. METHODS: This study included 58,504 individuals aged ≥30 years who participated in the Korea National Health and Nutrition Examination Survey 2010-2020. Trends in the prevalence, awareness, treatment, and control of chronic diseases and the difference in those between before and during the COVID-19 pandemic were analyzed using the SAS program PROC SURVEYREG. RESULTS: From 2010-2020, the awareness, treatment, and control in adults aged ≥30 years for hypertension and hypercholesterolemia continuously improved, whereas no significant change in the management indicators of diabetes mellitus was observed. The prevalence of hypertension, diabetes mellitus, and hypercholesterolemia in men increased from before to during the COVID- 19 pandemic. However, there was no significant change in the management indicators of hypertension and diabetes mellitus in men and women, and the awareness, treatment, and control rates for hypercholesterolemia increased by 5.5%p, 6.9%p, and 4.1%p respectively. CONCLUSIONS: In 2020, the first year of the COVID-19 pandemic, the prevalence of hypertension, diabetes mellitus, and hypercholesterolemia increased, but the management indicators of the chronic diseases did not significantly deteriorate. Considering the ongoing COVID-19 pandemic, it is necessary to monitor changes in chronic disease management indicators and to develop efficient and accessible chronic disease prevention and management programs.


Subject(s)
COVID-19 , Diabetes Mellitus , Hypercholesterolemia , Hypertension , Male , Adult , Humans , Female , Hypercholesterolemia/epidemiology , Pandemics/prevention & control , Nutrition Surveys , COVID-19/epidemiology , Hypertension/epidemiology , Hypertension/prevention & control , Diabetes Mellitus/therapy , Diabetes Mellitus/prevention & control , Chronic Disease , Republic of Korea/epidemiology , Prevalence , Risk Factors
4.
Front Public Health ; 9: 740946, 2021.
Article in English | MEDLINE | ID: covidwho-1775895

ABSTRACT

American Indian and Alaska Native (AI/AN) people suffer a disproportionate burden of diabetes and cardiovascular disease. Urban Indian Health Organizations (UIHOs) are an important source of diabetes services for urban AI/AN people. Two evidence-based interventions-diabetes prevention (DP) and healthy heart (HH)-have been implemented and evaluated primarily in rural, reservation settings. This work examines the capacity, challenges and strengths of UIHOs in implementing diabetes programs. Methods: We applied an original survey, supplemented with publicly-available data, to assess eight organizational capacity domains, strengths and challenges of UIHOs with respect to diabetes prevention and care. We summarized and compared (Fisher's and Kruskal-Wallis exact tests) items in each organizational capacity domain for DP and HH implementers vs. non-implementers and conducted a thematic analysis of strengths and challenges. Results: Of the 33 UIHOs providing services in 2017, individuals from 30 sites (91% of UIHOs) replied to the survey. Eight UIHOs (27%) had participated in either DP (n = 6) or HH (n = 2). Implementers reported having more staff than non-implementers (117.0 vs. 53.5; p = 0.02). Implementers had larger budgets, ~$10 million of total revenue compared to $2.5 million for non-implementers (p = 0.01). UIHO strengths included: physical infrastructure, dedicated leadership and staff, and community relationships. Areas to strengthen included: staff training and retention, ensuring sufficient and consistent funding, and data infrastructure. Conclusions: Strengthening UIHOs across organizational capacity domains will be important for implementing evidence-based diabetes interventions, increasing their uptake, and sustaining these interventions for AI/AN people living in urban areas of the U.S.


Subject(s)
Diabetes Mellitus , Indians, North American , Alaska , Diabetes Mellitus/prevention & control , Humans
5.
Molecules ; 27(3)2022 Jan 25.
Article in English | MEDLINE | ID: covidwho-1686895

ABSTRACT

Oxidative stress is involved in the onset and development of several human diseases, such as cardiovascular diseases, diabetes, ageing, cancer, and neurodegenerative diseases [...].


Subject(s)
Food Analysis , Phenols/analysis , Antioxidants/analysis , Cardiovascular Diseases/prevention & control , Diabetes Mellitus/prevention & control , Humans , Neoplasms/prevention & control , Neurodegenerative Diseases/prevention & control
7.
BMJ ; 375: n2938, 2021 11 26.
Article in English | MEDLINE | ID: covidwho-1537932

Subject(s)
Adrenergic beta-Antagonists/adverse effects , Blood Pressure/drug effects , Diabetes Mellitus/prevention & control , Hypertension/drug therapy , Thiazides/adverse effects , Adrenergic beta-Antagonists/therapeutic use , Aminobutyrates/pharmacology , Aminobutyrates/therapeutic use , Angiotensin Receptor Antagonists/pharmacology , Angiotensin Receptor Antagonists/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Animals , Biphenyl Compounds/pharmacology , Biphenyl Compounds/therapeutic use , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/therapy , COVID-19/virology , Calcium Channel Blockers/adverse effects , Calcium Channel Blockers/therapeutic use , Cats , Diabetes Mellitus/etiology , Diabetes Mellitus, Type 2/drug therapy , Dogs , Drug Combinations , Gastric Inhibitory Polypeptide/adverse effects , Gastric Inhibitory Polypeptide/pharmacology , Gastric Inhibitory Polypeptide/therapeutic use , Heart Sounds/physiology , History, 20th Century , Humans , Hypertension/complications , Immunization, Passive/methods , Immunization, Passive/statistics & numerical data , Incretins/adverse effects , Incretins/pharmacology , Incretins/therapeutic use , Insulin Glargine/adverse effects , Insulin Glargine/history , Insulin Glargine/pharmacology , Insulin Glargine/therapeutic use , Meta-Analysis as Topic , Randomized Controlled Trials as Topic , SARS-CoV-2/genetics , Thiazides/therapeutic use , Valsartan/pharmacology , Valsartan/therapeutic use , COVID-19 Serotherapy
8.
Health Aff (Millwood) ; 40(11): 1682-1687, 2021 11.
Article in English | MEDLINE | ID: covidwho-1502080

ABSTRACT

After years of research, Medicare agreed to pay for diabetes prevention programming, but few beneficiaries and providers have enrolled.


Subject(s)
Diabetes Mellitus , Medicare , Aged , Diabetes Mellitus/prevention & control , Humans , United States
10.
Int J Environ Res Public Health ; 18(14)2021 Jul 16.
Article in English | MEDLINE | ID: covidwho-1314655

ABSTRACT

Diabetes is considered an epidemic of the 21st century. On 11 March 2020, two months after the outbreak of COVID-19 (coronavirus disease of 2019) epidemic in China, the World Health Organization announced COVID-19 to be a pandemic. From that time, many hospitals and wards have started to function as both infectious and non-infectious ones; so did the Diabetes Clinic Institute of Rural Health in South-Eastern Poland. Considering the global importance of diabetes and its prevalence worldwide, it seemed important to investigate how the Diabetes Clinic passed through the individual phases of the pandemic, and the possibility of protecting hospitalized patients against future pandemic infection. We present detailed characteristics of the situation in a ward which used to treat non-infectious patients with diabetes only and, nowadays, has been obliged to take into account the risk of spreading SARS-Cov-2 (severe acute respiratory syndrome coronavirus-2) infection also. Moreover, we suggest solutions to avoid cases of infectious diseases in non-infectious wards in the future.


Subject(s)
COVID-19 , Diabetes Mellitus , Noncommunicable Diseases , China , Diabetes Mellitus/epidemiology , Diabetes Mellitus/prevention & control , Hospitals , Humans , Pandemics/prevention & control , Poland/epidemiology , Rural Health , SARS-CoV-2
11.
Biochimie ; 187: 94-109, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1252495

ABSTRACT

Despite the development of a number of vaccines for COVID-19, there remains a need for prevention and treatment of the virus SARS-CoV-2 and the ensuing disease COVID-19. This report discusses the key elements of SARS-CoV-2 and COVID-19 that can be readily treated: viral entry, the immune system and inflammation, and the cytokine storm. It is shown that the essential nutrients zinc, ω-3 polyunsaturated fatty acids (PUFAs), vitamin D and magnesium provide the ideal combination for prevention and treatment of COVID-19: prevention of SARS-CoV-2 entry to host cells, prevention of proliferation of SARS-CoV-2, inhibition of excessive inflammation, improved control of the regulation of the immune system, inhibition of the cytokine storm, and reduction in the effects of acute respiratory distress syndrome (ARDS) and associated non-communicable diseases. It is emphasized that the non-communicable diseases associated with COVID-19 are inherently more prevalent in the elderly than the young, and that the maintenance of sufficiency of zinc, ω-3 PUFAs, vitamin D and magnesium is essential for the elderly to prevent the occurrence of non-communicable diseases such as diabetes, cardiovascular diseases, lung diseases and cancer. Annual checking of levels of these essential nutrients is recommended for those over 65 years of age, together with appropriate adjustments in their intake, with these services and supplies being at government cost. The cost:benefit ratio would be huge as the cost of the nutrients and the testing of their levels would be very small compared with the cost savings of specialists and hospitalization.


Subject(s)
COVID-19/prevention & control , Fatty Acids, Omega-3/therapeutic use , Magnesium/therapeutic use , Noncommunicable Diseases/prevention & control , Vitamin D/therapeutic use , Zinc/therapeutic use , Aged , COVID-19/therapy , Cardiovascular Diseases/prevention & control , Cardiovascular Diseases/therapy , Cytokine Release Syndrome/therapy , Diabetes Mellitus/prevention & control , Diabetes Mellitus/therapy , Humans , Inflammation/therapy , Lung Diseases/prevention & control , Lung Diseases/therapy , Neoplasms/prevention & control , Neoplasms/therapy , Noncommunicable Diseases/therapy , Nutritional Status , SARS-CoV-2 , Vitamins/therapeutic use
13.
Obes Rev ; 22(9): e13301, 2021 09.
Article in English | MEDLINE | ID: covidwho-1249449

ABSTRACT

In 2016, the South African government proposed a 20% sugar-sweetened beverage (SSB) tax. Protracted consultations with beverage manufacturers and the sugar industry followed. This resulted in a lower sugar-based beverage tax, the Health Promotion Levy (HPL), of approximately 10% coming into effect in April 2018. We provide a synthesis of findings until April 2021. Studies show that despite the lower rate, purchases of unhealthy SSBs and sugar intake consumption from SSBs fell. There were greater reductions in SSB purchases among both lower socioeconomic groups and in subpopulations with higher SSB consumption. These subpopulations bear larger burdens from obesity and related diseases, suggesting that this policy improves health equity. The current COVID-19 pandemic has impacted food and nutritional security. Increased pandemic mortality among people with obesity, diabetes, and hypertension highlight the importance of intersectoral public health disease-prevention policies like the HPL, which should be strengthened.


Subject(s)
COVID-19/epidemiology , Health Promotion/methods , SARS-CoV-2 , Sugar-Sweetened Beverages/adverse effects , Sugar-Sweetened Beverages/economics , Taxes , Comorbidity , Consumer Behavior , Diabetes Mellitus/epidemiology , Diabetes Mellitus/prevention & control , Humans , Hypertension/epidemiology , Hypertension/prevention & control , Obesity/epidemiology , Obesity/prevention & control , Socioeconomic Factors , South Africa/epidemiology
14.
Ann Med ; 53(1): 581-586, 2021 12.
Article in English | MEDLINE | ID: covidwho-1171161

ABSTRACT

Although coronavirus disease 2019 (COVID-19) is a pandemic, it has several specificities influencing its outcomes due to the entwinement of several factors, which anthropologists have called "syndemics". Drawing upon Singer and Clair's syndemics model, I focus on synergistic interaction among chronic kidney disease (CKD), diabetes, and COVID-19 in Pakistan. I argue that over 36 million people in Pakistan are standing at a higher risk of contracting COVID-19, developing severe complications, and losing their lives. These two diseases, but several other socio-cultural, economic, and political factors contributing to structured vulnerabilities, would function as confounders. To deal with the critical effects of these syndemics the government needs appropriate policies and their implementation during the pandemic and post-pandemic. To eliminate or at least minimize various vulnerabilities, Pakistan needs drastic changes, especially to overcome (formal) illiteracy, unemployment, poverty, gender difference, and rural and urban difference.


Subject(s)
COVID-19/epidemiology , Diabetes Mellitus/epidemiology , Pandemics/prevention & control , Renal Insufficiency, Chronic/epidemiology , Syndemic , COVID-19/prevention & control , Climate Change/economics , Climate Change/statistics & numerical data , Confounding Factors, Epidemiologic , Developing Countries/economics , Developing Countries/statistics & numerical data , Diabetes Mellitus/economics , Diabetes Mellitus/prevention & control , Food Supply/economics , Food Supply/statistics & numerical data , Health Literacy/economics , Health Literacy/statistics & numerical data , Humans , Pakistan/epidemiology , Pandemics/economics , Politics , Poverty/economics , Poverty/statistics & numerical data , Renal Insufficiency, Chronic/economics , Renal Insufficiency, Chronic/prevention & control , Unemployment/statistics & numerical data
16.
Nutrients ; 13(2)2021 Feb 03.
Article in English | MEDLINE | ID: covidwho-1067767

ABSTRACT

African Americans have higher incidence of, and mortality from, many health-related problems than European Americans. They also have a 15 to 20-fold higher prevalence of severe vitamin D deficiency. Here we summarize evidence that: (i) this health disparity is partly due to insufficient vitamin D production, caused by melanin in the skin blocking the UVB solar radiation necessary for its synthesis; (ii) the vitamin D insufficiency is exacerbated at high latitudes because of the combination of dark skin color with lower UVB radiation levels; and (iii) the health of individuals with dark skin can be markedly improved by correcting deficiency and achieving an optimal vitamin D status, as could be obtained by supplementation and/or fortification. Moderate-to-strong evidence exists that high 25-hydroxyvitamin D levels and/or vitamin D supplementation reduces risk for many adverse health outcomes including all-cause mortality rate, adverse pregnancy and birth outcomes, cancer, diabetes mellitus, Alzheimer's disease and dementia, multiple sclerosis, acute respiratory tract infections, COVID-19, asthma exacerbations, rickets, and osteomalacia. We suggest that people with low vitamin D status, which would include most people with dark skin living at high latitudes, along with their health care provider, consider taking vitamin D3 supplements to raise serum 25-hydroxyvitamin D levels to 30 ng/mL (75 nmol/L) or possibly higher.


Subject(s)
COVID-19/etiology , COVID-19/prevention & control , Cholecalciferol/administration & dosage , Dietary Supplements , Health Status Disparities , Vitamin D Deficiency/ethnology , Vitamin D Deficiency/epidemiology , Black or African American , Alzheimer Disease/etiology , Alzheimer Disease/prevention & control , Antigens, Neoplasm , Dementia/etiology , Dementia/prevention & control , Diabetes Mellitus/etiology , Diabetes Mellitus/prevention & control , Female , Humans , Male , Prevalence , Status Asthmaticus/etiology , Status Asthmaticus/prevention & control , Vitamin D/analogs & derivatives , Vitamin D/blood , Vitamin D Deficiency/complications
18.
Front Endocrinol (Lausanne) ; 11: 584642, 2020.
Article in English | MEDLINE | ID: covidwho-945636

ABSTRACT

Diabetes is the second most prevalent non-communicable chronic diseases (NCDs) in patients with coronavirus disease 2019 (COVID-19) and is highly associated with increased incidence of disease severity and mortality. Individuals with diabetes and poor glycemic control have an even worse prognosis. Despite of the need/effectiveness of social distancing measures (i.e.: home confinement, quarantine and/or lockdown) during COVID-19 outbreak, preliminary findings showed an increase in negative behaviors during COVID-19 home confinement (i.e.: ~33.5% reduction in physical activity, ~28.6% (~3.10h) increase in sedentary behavior (i.e.: daily sitting, reclining and lying down time), and more unhealthy food consumption and meal pattern), which may have important clinical implications. For example, we estimated that this reduction in physical activity can increase the cases of type 2 diabetes (from ~7.2% to ~9.6%; ~11.1 million cases per year) and all-cause mortality (from ~9.4% to ~12.5%; ~1.7 million deaths per year) worldwide. Few weeks of reduction in physical activity levels result in deleterious effects on several cardiometabolic (i.e.: glycemic control, body composition, inflammatory cytokines, blood pressure, vascular function…) and functional parameters (i.e.: cardiorespiratory/muscle fitness, balance, agility…). In contrast, physical activity and exercise are important tools for preventing and treating diabetes and others NCDs. Home-based exercise programs are useful, safe and effective for the management of diabetes, and could be widely used during COVID-19 outbreak. In this context, there is an urgent need for recommending physical activity/exercise, during and beyond COVID-19 outbreak, for improving the management of diabetes, as well as to prevent the increase in global burden of COVID-19, diabetes and others NCDs.


Subject(s)
COVID-19/epidemiology , Diabetes Mellitus/prevention & control , Exercise , Health Promotion/methods , Needs Assessment/standards , Practice Guidelines as Topic/standards , SARS-CoV-2/isolation & purification , COVID-19/transmission , COVID-19/virology , Diabetes Mellitus/virology , Disease Outbreaks , Humans
SELECTION OF CITATIONS
SEARCH DETAIL